DNA damage response and development of targeted cancer treatments

ISSN： 0785-3890

Source： Annals of Medicine, Vol.39, Iss.6, 2007-01, pp. : 457-464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 9, 2015-05 ,pp. : 2246-2257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variants and response to cancer treatments

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1735-1736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Microtubule affinity‐regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non‐small cell lung cancer

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2072-2082

John Wiley & Sons Inc

Access to resources Recommend Favorite

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancer

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 6, 2015-12 ,pp. : 545-570

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histone Post-Translational Modifications in DNA Damage Response

Cytogenetic and Genome Research, Vol. 128, Iss. 1-3, 2010-04 ,pp. : 28-36

Karger

Access to resources Recommend Favorite